Signal return
—
Price move
+33.40%（$1.79）
First included
2026-07-16
Inclusion price
$5.36
Latest brief price
$7.15
Methodology: each issue's direction is a live signal — long/short opens or holds a position, neutral means flat, and every direction change opens, flips, or closes it. Returns are direction-aware (a short gains when the price falls) and compound across positions from first observation to the latest issue. "Price move" is the stock's own raw change, shown separately. Neither represents actual portfolio performance.
Brief History (2 issues)
July 17, 2026NeutralRapid scan6/10$7.15+33.40%
Up 33.4% to $7.15 as Lilly makes it official: $6.75 cash plus up to $2.50 in CVRs (up to $3.8B total); trading 6% above the cash means the market is pricing the CVR lottery — an arb-desk game, sidelines
July 16, 2026NeutralRapid scan4/10$5.36-5.47%
Down 5.5% to $5.36 as the unconfirmed pharma-takeover chatter deflates — rumor stocks don't get knife-catches